Bosco-Lévy, Pauline http://orcid.org/0000-0001-9763-5974
Favary, Clélia
Jové, Jérémy
Lassalle, Régis
Moore, Nicholas
Droz-Perroteau, Cécile
Article History
Received: 26 April 2019
Accepted: 6 September 2019
First Online: 21 October 2019
Compliance with ethical standards
:
: This study was done in a pseudonymized database, not requiring patient consent. It was reviewed by INSERM internal processes, which did not oppose it. INSERM CIC1401 at that time had permanent access to the 1/97 sample of SNDS, pending INSERM approval.
: Dr. P. Bosco-Lévy, C Favary, J Jové, R Lassalle, and C Droz-Perroteau have nothing to disclose.Bordeaux PharmacoEpi (director Pr. N. Moore) has received grants from many pharmaceutical companies (Novartis, Bayer, Boehringer Ingelheim, Merck-Serono, etc., see ExternalRef removed for a complete list of all research projects) to the University of Bordeaux for regulatory required PASS studies. He declares personal expert consulting fees from Merck-Serono, Ipsen, GSK, Bayer, Sanofi, outside the submitted work.